Description
Composition
Each film-coated tablet contains: olmesartan medoxomil (micronized) 40 mg, amlodipine 5 mg, hydrochlorothiazide 12.5 mg.
Properties
A triple combination for high blood pressure: an angiotensin II receptor blocker (olmesartan), a calcium channel blocker (amlodipine) and a thiazide diuretic (hydrochlorothiazide).
Indications
Treatment of hypertension. Not intended for initial therapy of hypertension.
Dosage and administration
Once daily. The dose is selected by the doctor based on previous therapy and may be increased at 2-week intervals. Maximum dose: 40/10/25 mg per day.
Contraindications
Anuria; hypersensitivity to any component or to other sulfonamide-derived drugs; use with aliskiren in patients with diabetes; pregnancy (can harm the unborn baby; stop as soon as pregnancy is detected). Breastfeeding is not recommended.
Precautions
Low blood pressure in patients with low fluid or salt levels; kidney or liver problems; changes in potassium, sodium, glucose and uric acid levels; lupus; sudden vision changes or eye pain (stop and see a doctor); severe chronic diarrhea.
Side effects
Most common: swelling of the legs, headache, dizziness, fatigue, nausea, muscle spasms, diarrhea, upper respiratory and urinary tract infections.
Packaging
3 strips of 10 film-coated tablets.
Manufacturer: Averroes Pharma (Egypt)
